![Marc Semigran](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Marc Semigran
Corporate Officer/Principal presso
Harvard Medical School
Profilo
Marc Semigran occupa la posizione di vicepresidente senior delle scienze mediche presso MyoKardia, Inc. In precedenza ha occupato la posizione di direttore medico presso The General Hospital Corp., membro di medicina interna presso The General Hospital Corp. e professore associato presso la Harvard Medical School. Marc Semigran si è laureato alla Harvard University e ha conseguito un dottorato alla Harvard Medical School.
Posizioni attive di Marc Semigran
| Società | Posizione | Inizio |
|---|---|---|
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 01/01/2010 |
Broadview Ventures, Inc.
 Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Consulente / Consigliere | - |
Precedenti posizioni note di Marc Semigran
| Società | Posizione | Fine |
|---|---|---|
| EDGEWISE THERAPEUTICS, INC. | Corporate Officer/Principal | 22/01/2025 |
Renovacor Holdings, Inc.
 Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Direttore Tecnico/Scientifico/R&S | 01/09/2021 |
| MYOKARDIA, INC. | Direttore Tecnico/Scientifico/R&S | 01/05/2021 |
The General Hospital Corp.
 The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Corporate Officer/Principal | 01/11/2016 |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Direttore Tecnico/Scientifico/R&S | 01/01/2006 |
Formazione di Marc Semigran
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
91
Relazioni di 1° grado
9
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 9 |
|---|---|
MyoKardia, Inc.
 MyoKardia, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that discovers, develops and commercializes therapies for the treatment of cardiovascular diseases | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services Functions as a non profit organization that operates general hospital | Health Services |
Broadview Ventures, Inc.
Broadview Ventures, Inc. Investment ManagersFinance Broadview Ventures invests in companies located across the globe, primarily in North America, Europe and Israel. The firm targets companies operating in the fields of healthcare and technology sectors. It provides financing for seed and early-stage capital requirements. The firm makes follow-on investments. | Finance |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Edgewise Therapeutics, Inc.
 Edgewise Therapeutics, Inc. BiotechnologyHealth Technology Develops novel therapies for skeletal muscle diseases | Health Technology |
Renovacor Holdings, Inc.
Renovacor Holdings, Inc. BiotechnologyHealth Technology Develops transformative gene therapy | Health Technology |
Social Capital Suvretta Holdings Corp. III
 Social Capital Suvretta Holdings Corp. III Financial ConglomeratesFinance Operates as a blank check company | Finance |
Renovacor, Inc.
 Renovacor, Inc. BiotechnologyHealth Technology Engages in research and development for precision gene therapies and genetically driven cardiovascular diseases | Health Technology |
